Since its establishment with great dedication and effort in 1975, the first and the most important goal of our company has been contributing to public health and the pharmaceutical industry. We have always endeavoured to achieve the better and the favourable by using the strength taken from our sector for the benefit of the sector. Our mission as Drogsan Pharmaceuticals, is being a leading organization, which keeps its priority on human health, its efficiency and effectiveness at the top level, grows with continuous improvement, operates under moral and ethical values, and whose employees are proud to be a part of. We institutionalized our production and service infrastructure, with our vision to be a pharmaceutical company that is well-known, esteemed, followed and permanent on both local and international platforms.
As a company that works for creating value in health, we are conscious of fulfilling our duties and responsibilities against our public, physicians, pharmacists, customers, suppliers and employees at our best in all circumstances. We aim to be an institution following the latest developments in the health sector which has been changing at a dizzying speed, adapting to the innovations, and converting this process of change into a build-up and growth energy.
By synthesizing with industrial innovations, we will keep on transforming the experience we gained in the past years into the best quality products and services for the use of our public, physicians, pharmacists, and all health sector stakeholders in the coming years. Because for us, “respect to health” means first and foremost…
Contact
Dilmenler Cad. Aslanoba Plaza No: 19/7A Mahmut Bey Mah.
34218 Bağcılar – İSTANBUL
Phone: + 90 (0212) 445 06 00
Fax: + 90 (0212) 445 06 16
Murat Barlas, the longest serving board member for the Turkish Pharmaceutical Manufacturers Association, discusses the need for a new perspective in government-industry relations in the Turkish pharmaceutical industry, and the…
The Turkish minister of labour and social security comments on the country’s deep commitment to providing for the health of citizens while maintaining sustainability and continuous improvement of services. How…
Novo Nordisk Turkey has taken a degree of leadership by working to facilitate and encourage cooperation and collaboration between different stakeholders in the diabetes management ecosystem. For general manager Şebnem…
Turkey is a key market in the region for Servier, says general manager Philippe Méa, largely due to the country’s relatively strong and stable vision for the healthcare industry. The…
Turkey has been a high priority market for Actelion since the company’s relatively recent beginnings, and the general manager of the local affiliate discusses his affiliate efforts to improve awareness…
Bayer Turkey’s healthcare division head discusses how the company adapted to the post 2009 pharmaceutical pricing environment by shrinking their portfolio and focusing strongly on key growth products, launched recently…
Medipol hospital’s medical director discusses the private institution’s current role in the Turkish healthcare system, and their plans for expansion in the coming years. How did Medipol come into existence,…
Professor Burak Erman, the leader of the Drug Research Center at Koç University, and his colleague Hakan Orer, discuss the early activities of the center as a catalyst for collaboration…
Janssen’s MD in Turkey discusses how true innovation is still recognized in Turkey, and how products that meet unmet medical needs are given early access to the country and reimbursement.…
IMS’s top consultant in Turkey discusses the common pattern that companies in Turkey have and must follow to adapt to today’s market, and the importance of heeding market signals, such…
The managing director of Otsuka’s 50-50 joint venture with Turkish giant Abdi Ibrahim, Abdi Ibrahim Otsuka, discusses the mutual advantage the companies can offer each other, and branding Abdi Ibrahim…
Turkey’s Minister of Health discusses the major achievements of his party in the area of healthcare since 2003, and the key priorities for the country’s healthcare system moving forward. During…
See our Cookie Privacy Policy Here
